Cudraflavanone A, a prenylated flavanone, has been reported to inhibit topoisomerase I and protein kinase C (PKC) activity, leading to the induction of apoptotic cell death in human cancer cells [28] and vascular smooth muscle cell growth via a protein kinase B (Akt)-dependent pathway [29]. Here, PRRT2 is linked to cancer.